Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Genovefa Kolovou, Vana Kolovou & Sophie Mavrogeni. (2015) Lipidomics in vascular health: current perspectives. Vascular Health and Risk Management 11, pages 333-342.
Read now
Read now
Rishi Puri, MyNgan Duong, Kiyoko Uno, Yu Kataoka & Stephen J Nicholls. (2012) The emerging role of plasma lipidomics in cardiovascular drug discovery. Expert Opinion on Drug Discovery 7:1, pages 63-72.
Read now
Read now
Peter P Toth & Thomas D Dayspring. (2011) Drug safety evaluation of rosuvastatin. Expert Opinion on Drug Safety 10:6, pages 969-986.
Read now
Read now
Articles from other publishers (35)
Carola S. König, Amar Mann, Rob McFarlane, John Marriott, Malcolm Price & Sudarshan Ramachandran. (2023) Age and the Residual Risk of Cardiovascular Disease following Low Density Lipoprotein-Cholesterol Exposure. Biomedicines 11:12, pages 3208.
Crossref
Crossref
José Guedes da Silva Júnior, Hallysson Douglas Andrade de Araújo, Ismael Gomes da Rocha, Jacinto Costa da Silva Neto, Ronaldo Nascimento Oliveira, Shalom Pôrto de Oliveira Assis & Vera Lúcia de Menezes Lima. (2022) Antihyperlipidemic Activity of Glycoconjugated Phthalimides in Mice Submitted to a Model of Dyslipidemia and Insulin Resistance. Chemistry & Biodiversity 19:10.
Crossref
Crossref
Rodrigo Damián García, Joana Antonela Asensio, Diahann Jeanette Perdicaro & María de los Ángeles Peral. (2022) The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular
Diseases. Current Vascular Pharmacology 20:3, pages 244-259.
Crossref
Crossref
Andrea Denegri & Giuseppe Boriani. (2021) High Sensitivity C-reactive Protein (hsCRP) and its Implications in Cardiovascular Outcomes. Current Pharmaceutical Design 27:2, pages 263-275.
Crossref
Crossref
E. V. Sayutina, M. M. Shamuilova, L. I. Butorova, E. M. Tuayeva & A. L. Vertkin. (2020) Statin therapy in patients with high and very high cardiovascular risk: an optimal approach. Cardiovascular Therapy and Prevention 19:5, pages 2696.
Crossref
Crossref
Sreenivas Reddy, Vikas Kadiyala, Jeet Ram Kashyap, Raghavendra Rao, Hithesh Reddy, Jaspreet Kaur, Naindeep Kaur & Vadivelu Ramalingam. (2020) Comparison of Intravascular Ultrasound Virtual Histology Parameters in Diabetes versus Non-Diabetes with Acute Coronary Syndrome. Cardiology 145:9, pages 570-577.
Crossref
Crossref
Eyup Avci, Ahmet Dolapoglu & Didar Elif Akgun. 2018. Cholesterol - Good, Bad and the Heart. Cholesterol - Good, Bad and the Heart.
Rishi Puri, Christie M. Ballantyne, Ron C. Hoogeveen, Mingyuan Shao, Philip Barter, Peter Libby, M. John Chapman, Raimund Erbel, Benoit J. Arsenault, Joel S. Raichlen, Steven E. Nissen & Stephen J. Nicholls. (2017) Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN. Atherosclerosis 263, pages 137-144.
Crossref
Crossref
Marc Badoz, Marion Chatot, Rémy Hechema, Romain Chopard, Nicolas Meneveau & François Schiele. (2016) Effect of Fractional Flow Reserve (≤0.90 vs >0.90) on Long-Term Outcome (>10 Years) in Patients With Nonsignificant Coronary Arterial Narrowings. The American Journal of Cardiology 118:4, pages 465-472.
Crossref
Crossref
Rishi Puri, Steven E. Nissen, Ransi Somaratne, Leslie Cho, John J.P. Kastelein, Christie M. Ballantyne, Wolfgang Koenig, Todd J. Anderson, Jingyuan Yang, Helina Kassahun, Scott M. Wasserman, Robert Scott, Marilyn Borgman & Stephen J. Nicholls. (2016) Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV). American Heart Journal 176, pages 83-92.
Crossref
Crossref
Tadateru Takayama, Sei Komatsu, Yasunori Ueda, Seiji Fukushima, Takafumi Hiro, Atsushi Hirayama & Satoshi Saito. (2016) Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial). The American Journal of Cardiology 117:8, pages 1206-1212.
Crossref
Crossref
Milla Machado Fumian, Nadia Alice Vieira da Motta, Rodolfo Maia, Carlos Alberto Manssour Fraga, Eliezer Jesus Barreiro & Fernanda Carla Ferreira de Brito. (2016) LASSBio-1425, an analog of thalidomide, decreases triglyceride and increases HDL cholesterol levels by inhibition of TNF-α production. International Journal of Cardiology 202, pages 497-499.
Crossref
Crossref
R. Erbel. (2015) Progression der koronaren AtheroskleroseProgression of coronary atherosclerosis. Herz 40:6, pages 835-836.
Crossref
Crossref
Raimund Erbel. (2015) Progression und Regression atherosklerotischer PlaquesProgression and regression of atherosclerotic plaques. Herz 40:6, pages 855-862.
Crossref
Crossref
Søren Auscher, Laurits Heinsen, Koen Nieman, Kristina Høeg Vinther, Brian Løgstrup, Jacob Eifer Møller, Alexander Broersen, Pieter Kitslaar, Jess Lambrechtsen & Kenneth Egstrup. (2015) Effects of intensive lipid-lowering therapy on coronary plaques composition in patients with acute myocardial infarction: Assessment with serial coronary CT angiography. Atherosclerosis 241:2, pages 579-587.
Crossref
Crossref
Ashley K. Vavra & Mark K. Eskandari. (2015) Treatment options for symptomatic carotid stenosis: Timing and approach. The Surgeon 13:1, pages 44-51.
Crossref
Crossref
Takafumi Hiro, Atsushi Hirayama, Yasunori Ueda, Sei Komatsu, Hiroshi Matsuoka, Tadateru Takayama, Masaharu Ishihara, Takatoshi Hayashi, Satoshi Saito & Kazuhisa Kodama. (2014) Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study. Journal of Cardiology 64:6, pages 501-507.
Crossref
Crossref
Brian Stegman, Rishi Puri, Leslie Cho, Mingyuan Shao, Christie M. Ballantyne, Phillip J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Yu Kataoka, Steven E. Nissen & Stephen J. Nicholls. (2014) High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN. Diabetes Care 37:11, pages 3114-3120.
Crossref
Crossref
Rishi Puri, Steven E. Nissen, Mingyuan Shao, Christie M. Ballantyne, Phillip J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Yu Kataoka & Stephen J. Nicholls. (2014) Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy. JACC: Cardiovascular Imaging 7:10, pages 1013-1022.
Crossref
Crossref
Qing Sun, Lu Zhang, Shuwen Guo, Min Zheng, Dandan Yang, Chenglong Zheng, Jiani Wu, Jian Liu & Jingping Wu. (2014) Tiaozhi Tongmai Granules reduce atherogenesis and promote the expression of ATP-binding cassette transporter A1 in rabbit atherosclerotic plaque macrophages and the liver. Journal of Traditional Chinese Medical Sciences 1:1, pages 38-48.
Crossref
Crossref
R. Puri, P. Libby, S. E. Nissen, K. Wolski, C. M. Ballantyne, P. J. Barter, M. J. Chapman, R. Erbel, J. S. Raichlen, K. Uno, Y. Kataoka, E. M. Tuzcu & S. J. Nicholls. (2014) Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN. European Heart Journal - Cardiovascular Imaging 15:4, pages 380-388.
Crossref
Crossref
Seigo Ishino, Mikako Ogawa, Ikuo Mori, Satoshi Nishimura, Shota Ikeda, Taku Sugita, Tatsuo Oikawa, Takashi Horiguchi & Yasuhiro Magata. (2013) 18F-FDG PET and intravascular ultrasonography (IVUS) images compared with histology of atherosclerotic plaques: 18F-FDG accumulates in foamy macrophages. European Journal of Nuclear Medicine and Molecular Imaging 41:4, pages 624-633.
Crossref
Crossref
Rishi PuriSteven E. NissenPeter LibbyMingyuan ShaoChristie M. BallantynePhillip J. BarterM. John ChapmanRaimund ErbelJoel S. RaichlenKiyoko UnoYu KataokaStephen J. Nicholls. (2013) C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy. Circulation 128:22, pages 2395-2403.
Crossref
Crossref
S. Yla-Herttuala, J. F. Bentzon, M. Daemen, E. Falk, H. M. Garcia-Garcia, J. Herrmann, I. Hoefer, S. Jauhiainen, J. W. Jukema, R. Krams, B. R. Kwak, N. Marx, M. Naruszewicz, A. Newby, G. Pasterkamp, P. W. J. C. Serruys, J. Waltenberger, C. Weber & L. Tokgozoglu. (2013) Stabilization of atherosclerotic plaques: an update. European Heart Journal 34:42, pages 3251-3258.
Crossref
Crossref
R. Puri, S. E. Nissen, M. Shao, C. M. Ballantyne, P. J. Barter, M. J. Chapman, R. Erbel, P. Libby, J. S. Raichlen, K. Uno, Y. Kataoka & S. J. Nicholls. (2013) Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. European Heart Journal 34:41, pages 3182-3190.
Crossref
Crossref
Jason Constantinou, Parveen Jayia & George Hamilton. (2013) Best evidence for medical therapy for carotid artery stenosis. Journal of Vascular Surgery 58:4, pages 1129-1139.
Crossref
Crossref
Rishi Puri, Steven E. Nissen, Christie M. Ballantyne, Phillip J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Julie St. John, Kathy Wolski, Kiyoko Uno, Yu Kataoka & Stephen J. Nicholls. (2013) Factors underlying regression of coronary atheroma with potent statin therapy. European Heart Journal 34:24, pages 1818-1825.
Crossref
Crossref
Katsumi Miyauchi & Kausik Ray. (2013) A review of statin use in patients with acute coronary syndrome in Western and Japanese populations. Journal of International Medical Research 41:3, pages 523-536.
Crossref
Crossref
Gaofeng Zhao, Yong-Ming Yu, Masao Kaneki, Ronald G. Tompkins & Alan J. Fischman. (2013) Simvastatin Protects Hepatocytes From Apoptosis by Suppressing the TNF-α/Caspase-3 Signaling Pathway in Mice With Burn Injury. Annals of Surgery 257:6, pages 1129-1136.
Crossref
Crossref
Xin Zhang, Hairong Wang, Shanshan Liu, Peihua Gong, Jie Lin, Jide Lu, Jianping Qiu & Xiaojiong Lu. (2012) Intensive-Dose Atorvastatin Regimen Halts Progression of Atherosclerotic Plaques in New-onset Unstable Angina With Borderline Vulnerable Plaque Lesions. Journal of Cardiovascular Pharmacology and Therapeutics 18:2, pages 119-125.
Crossref
Crossref
Young Joon Hong, Myung Ho Jeong, Youngkeun Ahn, Sang Wook Kim, Jang Ho Bae, Seung Ho Hur, Tae Hoon Ahn, Seung Woon Rha, Kee Sik Kim, In Ho Chae, Jong Hyun Kim, Kyeong Ho Yun & Seok Kyu Oh. (2012) Effect of pitavastatin treatment on changes of plaque volume and composition according to the reduction of high-sensitivity C-reactive protein levels. Journal of Cardiology 60:4, pages 277-282.
Crossref
Crossref
Vanessa P Araujo, Manuel H Aguiar-Oliveira, Joselina L M Oliveira, Hertaline M N Rocha, Carla R P Oliveira, Tânia M A Rodrigues, Marco A Nunes, Isabella M P A Britto, Roberto Ximenes, Jose A S Barreto-Filho, Rafael A Meneguz-Moreno, Rossana M C Pereira, Eugênia H O Valença, Luiz A Oliveira-Neto, Taisa A R Vicente, Amanda Blackford & Roberto Salvatori. (2012) Arrest of atherosclerosis progression after interruption of GH replacement in adults with congenital isolated GH deficiency. European Journal of Endocrinology 166:6, pages 977-982.
Crossref
Crossref
Pedro R. Moreno, Meeranani Purushothaman & K‐Raman Purushothaman. (2012) Plaque neovascularization: defense mechanisms, betrayal, or a war in progress. Annals of the New York Academy of Sciences 1254:1, pages 7-17.
Crossref
Crossref
Hideaki Kaneda, Mitsuyasu Terashima & Hiroshi Yamaguchi. (2012) The Role of Intravascular Ultrasound in the Determination of Progression and Regression of Coronary Artery Disease. Current Atherosclerosis Reports 14:2, pages 175-185.
Crossref
Crossref
Stephen J. Nicholls, Christie M. Ballantyne, Philip J. Barter, M. John Chapman, Raimund M. Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Marilyn Borgman, Kathy Wolski & Steven E. Nissen. (2011) Effect of Two Intensive Statin Regimens on Progression of Coronary Disease. New England Journal of Medicine 365:22, pages 2078-2087.
Crossref
Crossref